Mar 6 |
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
|
Mar 5 |
Inovio Pharmaceuticals Q4 2023 Earnings Preview
|
Feb 21 |
Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know
|
Feb 21 |
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
|
Feb 14 |
Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference Transcript
|
Feb 12 |
Inovio (INO) Moves 17.4% Higher: Will This Strength Last?
|
Feb 7 |
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Feb 6 |
Inovio: Planning A BLA To Reverse Its Long Path Of Misfortunes
|
Feb 2 |
INOVIO Reports Inducement Grant Under Inducement Plan
|
Jan 30 |
How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
|